The prevalence of allergic diseases, especially allergic rhinitis and urticaria, is steadily increasing worldwide and has a marked effect on patients’ quality of life.
International evidence-based medicine guidelines for allergic rhinitis and urticaria clearly recommend antihistamines as the first-line therapeutic approach.
During this Symposium, three world-renowned experts will provide the very latest information concerning the state-of-the-art and research into antihistamines.
Professor Martin K. Church will explain how to perfect antihistamines, identify which is the ideal antihistamine for a specific patient, its mechanism of action and the characteristics required for it to be effective with a good safety profile.
Professor Jean Bousquet will discuss the importance of evidence-based medicine in the treatment and control of allergic diseases.
And finally, Professor Giorgio Walter Canonica will show how patient quality of life has improved with the development of new antihistamines.